C4 Therapeutics, Inc. (NASDAQ:CCCC) Expected to Announce Earnings of -$0.61 Per Share
Brokerages predict that C4 Therapeutics, Inc. (NASDAQ:CCCC – Get Rating) will post earnings per share (EPS) of ($0.61) for the current quarter, according to Zacks. Six analysts have made estimates for C4 Therapeutics’ earnings. The lowest EPS estimate is ($0.64) and the highest is ($0.60). C4 Therapeutics reported earnings of ($0.49) per share during the […]